Abstract

We revised our hypothesis that the absence of motor behavior impairments at the presymptomatic stage of Parkinsonism, when degeneration of nigrostriatal dopaminergic neurons has already occurred, is the result of compensatory maintenance of a normal extracellular dopamine (DA) concentration in the striatum. We used microdialysis to measure extracellular levels of DA, its precursor L-dihydroxyphenylalanine (L-DOPA), and its metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in mouse striatum in a model of the presymptomatic stage of Parkinsonism. This stage was induced by a single subcutaneous injection of the neurotoxin precursor 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine (MPTP) at a dose of 12 mg/kg. At 14 days after MPTP injection, the extracellular DA content substantially decreased as compared to the control; however, it did not result in alterations of motor behavior, probably due to compensatory processes directed, not to the maintenance of extracellular DA at the normal level, but rather to the elevation of neuronal sensitivity to DA. The extracellular L-DOPA content remained at the normal level. We did not find any changes in the DOPAC and HVA contents.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.